Literature DB >> 20817414

Impaired insight in patients with newly diagnosed nonaffective psychotic disorders with and without deficit features.

Hanan D Trotman1, Brian Kirkpatrick, Michael T Compton.   

Abstract

Patients with schizophrenia who have primary, enduring negative symptoms, or the deficit syndrome, have poorer psychosocial functioning but lesser clinical distress compared with nondeficit patients. Poor awareness of impairment in patients with deficit schizophrenia may contribute to this seeming contradiction. We hypothesized that poor insight would be present early in the course of illness in deficit patients, and that those with deficit features would have greater impairment in insight than those without deficit features. One-hundred one first-episode patients with nonaffective psychotic disorders were categorized into deficit (n=31) and nondeficit (n=70) groups. The deficit patients had significantly poorer insight than nondeficit patients when rated using a self-report questionnaire, and nearly significantly poorer insight rated by clinical researchers. Further, this effect remained for self-rated insight and reached statistical significance for researcher-rated insight after controlling for positive, negative, and general psychopathology symptoms. These results suggest that the treatment of deficit patients may be particularly complicated by poor insight.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 20817414      PMCID: PMC2999647          DOI: 10.1016/j.schres.2010.08.024

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  49 in total

Review 1.  Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac?

Authors:  P F Buckley; S M Stahl
Journal:  Acta Psychiatr Scand       Date:  2007-02       Impact factor: 6.392

2.  Prefrontal cortex and insight in schizophrenia: a volumetric MRI study.

Authors:  Adegboyega Sapara; Michael Cooke; Dominic Fannon; Alan Francis; Robert W Buchanan; Anantha P P Anilkumar; Ian Barkataki; Ingrid Aasen; Elizabeth Kuipers; Veena Kumari
Journal:  Schizophr Res       Date:  2006-11-13       Impact factor: 4.939

3.  The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectable.

Authors:  Georges Gharabawi; Cynthia Bossie; Ibrahim Turkoz; Mary Kujawa; Ramy Mahmoud; George Simpson
Journal:  J Nerv Ment Dis       Date:  2007-12       Impact factor: 2.254

4.  Mode of onset of psychosis and family involvement in help-seeking as determinants of duration of untreated psychosis.

Authors:  Michael T Compton; Victoria H Chien; Amy S Leiner; Sandra M Goulding; Paul S Weiss
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-07-05       Impact factor: 4.328

5.  The relation between neurocognitive dysfunction and impaired insight in patients with schizophrenia.

Authors:  Viktoria Simon; Marc De Hert; Martien Wampers; Joseph Peuskens; Ruud van Winkel
Journal:  Eur Psychiatry       Date:  2008-12-13       Impact factor: 5.361

6.  Family-level predictors and correlates of the duration of untreated psychosis in African American first-episode patients.

Authors:  Michael T Compton; Sandra M Goulding; Tynessa L Gordon; Paul S Weiss; Nadine J Kaslow
Journal:  Schizophr Res       Date:  2009-10-14       Impact factor: 4.939

7.  Health services determinants of the duration of untreated psychosis among African-American first-episode patients.

Authors:  Michael T Compton; Claire E Ramsay; Ruth S Shim; Sandra M Goulding; Tynessa L Gordon; Paul S Weiss; Benjamin G Druss
Journal:  Psychiatr Serv       Date:  2009-11       Impact factor: 3.084

8.  Insight correlates in child- and adolescent-onset first episodes of psychosis: results from the CAFEPS study.

Authors:  M Parellada; D Fraguas; I Bombín; S Otero; J Castro-Fornieles; I Baeza; A Gonzalez-Pinto; M Graell; C Soutullo; B Paya; C Arango
Journal:  Psychol Med       Date:  2008-12-18       Impact factor: 7.723

9.  Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study.

Authors:  Gregory P Strauss; Martin Harrow; Linda S Grossman; Cherise Rosen
Journal:  Schizophr Bull       Date:  2008-12-18       Impact factor: 9.306

10.  Is "clinical" insight the same as "cognitive" insight in schizophrenia?

Authors:  Gary Donohoe; Judy Hayden; Nicola McGlade; Cara O'Gráda; Teresa Burke; Sandra Barry; Caragh Behan; Timothy G Dinan; Eadbhard O'Callaghan; Michael Gill; Aiden P Corvin
Journal:  J Int Neuropsychol Soc       Date:  2009-05       Impact factor: 2.892

View more
  7 in total

1.  Progress in the study of negative symptoms.

Authors:  Brian Kirkpatrick
Journal:  Schizophr Bull       Date:  2014-03       Impact factor: 9.306

2.  Attacking Heterogeneity in Schizophrenia by Deriving Clinical Subgroups From Widely Available Symptom Data.

Authors:  Dwight Dickinson; Danielle N Pratt; Evan J Giangrande; MeiLin Grunnagle; Jennifer Orel; Daniel R Weinberger; Joseph H Callicott; Karen F Berman
Journal:  Schizophr Bull       Date:  2018-01-13       Impact factor: 9.306

Review 3.  Primary, Enduring Negative Symptoms: An Update on Research.

Authors:  Brian Kirkpatrick; Armida Mucci; Silvana Galderisi
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

4.  The "Insight Paradox" in Schizophrenia: Magnitude, Moderators and Mediators of the Association Between Insight and Depression.

Authors:  Martino Belvederi Murri; Mario Amore; Pietro Calcagno; Matteo Respino; Valentina Marozzi; Mattia Masotti; Michele Bugliani; Marco Innamorati; Maurizio Pompili; Silvana Galderisi; Mario Maj
Journal:  Schizophr Bull       Date:  2016-04-11       Impact factor: 9.306

5.  EPA guidance on assessment of negative symptoms in schizophrenia.

Authors:  S Galderisi; A Mucci; S Dollfus; M Nordentoft; P Falkai; S Kaiser; G M Giordano; A Vandevelde; M Ø Nielsen; L B Glenthøj; M Sabé; P Pezzella; I Bitter; W Gaebel
Journal:  Eur Psychiatry       Date:  2021-02-18       Impact factor: 5.361

6.  Identifying persistent negative symptoms in first episode psychosis.

Authors:  Cindy L Hovington; Michael Bodnar; Ridha Joober; Ashok K Malla; Martin Lepage
Journal:  BMC Psychiatry       Date:  2012-12-06       Impact factor: 3.630

7.  Dynamic Interplay Between Insight and Persistent Negative Symptoms in First Episode of Psychosis: A Longitudinal Study.

Authors:  Delphine Raucher-Chéné; Michael Bodnar; Katie M Lavigne; Ashok Malla; Ridha Joober; Martin Lepage
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.